|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||91.80 - 91.80|
|52-week range||77.45 - 97.30|
|Beta (5Y monthly)||0.51|
|PE ratio (TTM)||23.26|
|Forward dividend & yield||3.22 (3.51%)|
|Ex-dividend date||04 Mar 2021|
|1y target est||N/A|
Investors are likely to focus on pipeline updates besides top and bottom-line numbers when Incyte (INCY) reports second-quarter 2021 results.
Glaxo (GSK) beats earnings as well as revenues estimates in the second quarter of 2021. Stock up.
Let us take a look at five drug/biotech companies - PFE, GSK, BMY, BMRN and TLRY - which are gearing up for their earnings release.